Boston Scientific BSX
NYSE BSX
$43.22 -0.43 (-0.99%)
As of: Oct 1, 2026 · 3:56 PM EDT

Boston Scientific (BSX) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Boston Scientific's Liabilities and Shareholders Equity was $45.22 billion in Q2 2026, up 8.8% from $41.56 billion a year earlier and up 2.0% from the prior quarter.

Analysis

Boston Scientific (BSX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Boston Scientific came in at $43.67 billion, up 10.9% from FY2024.

  • Liabilities and Shareholders Equity has now increased for nine consecutive years, with a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $39.4 billion in FY2024 (+12.1%), $35.14 billion in FY2023 (+8.2%), $32.47 billion in FY2022 (+0.7%) and $32.23 billion in FY2021 (+4.7%).
  • The Q2 2026 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to Q2 2009.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for 38 straight quarters, with growth averaging 11.0% over the last eight quarters.
  • The year-over-year growth in Liabilities and Shareholders Equity has ranged between 0.2% (Q3 2022) and 12.2% (Q3 2025) over the last five years.
  • Per Business Quant data, BSX's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $44.35 billion (Q1 2026), $43.67 billion (Q4 2025) and $42.71 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Agilent Technologies 48.58 Bn 41.47 Bn 1.04 Bn 13.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45.22 Bn
Mar 31, 2026 44.35 Bn
Dec 31, 2025 43.67 Bn
Sep 30, 2025 42.71 Bn
Jun 30, 2025 41.56 Bn
Mar 31, 2025 40.14 Bn
Dec 31, 2024 39.40 Bn
Sep 30, 2024 38.08 Bn
Jun 30, 2024 37.11 Bn
Mar 31, 2024 36.67 Bn
Dec 31, 2023 35.14 Bn
Sep 30, 2023 34.04 Bn
Jun 30, 2023 33.60 Bn
Mar 31, 2023 32.89 Bn
Dec 31, 2022 32.47 Bn
Sep 30, 2022 31.95 Bn
Jun 30, 2022 32.19 Bn
Mar 31, 2022 32.34 Bn
Dec 31, 2021 32.23 Bn
Sep 30, 2021 31.88 Bn
API Access

Boston Scientific Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BSX&period=max&api_key=YOUR_API_KEY